| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/22/1998 | DE19730990A1 New (amidino-phenyl)-(benzo:dioxolo-methyl)oxo-pyrrolo:pyrrole compounds |
| 01/22/1998 | CA2262814A1 Highly productive packaging lines_ |
| 01/22/1998 | CA2260284A1 Compositions containing at least one nucleic acid |
| 01/22/1998 | CA2260216A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
| 01/22/1998 | CA2260061A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/22/1998 | CA2260058A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/22/1998 | CA2260034A1 Cationic amphiphile/dna complexes |
| 01/22/1998 | CA2259966A1 Compounds and methods for modulating cell adhesion |
| 01/22/1998 | CA2259371A1 Therapeutic multispecific compounds comprised of anti-fc.alpha. receptor antibodies |
| 01/22/1998 | CA2259136A1 Pituitary differentiation factor and methods of use thereof |
| 01/22/1998 | CA2257822A1 Infectious papillomavirus pseudoviral particles |
| 01/21/1998 | EP0819758A2 Cationic vehicle: DNA complexes and their use in gene therapy |
| 01/21/1998 | EP0819687A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/21/1998 | EP0819686A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/21/1998 | EP0819434A1 Use of PHMB for the treatment of tumors |
| 01/21/1998 | EP0819433A2 Compositions for increasing the efficacy of cancer drugs with tea catechin and/or theaflavin |
| 01/21/1998 | EP0819432A1 Antitumor agents comprising as the principal agent compounds containing silicon and nitrogen |
| 01/21/1998 | EP0819172A1 Polynucleotide immunogenic agents |
| 01/21/1998 | EP0819169A1 Methods for screening compounds for estrogenic activity |
| 01/21/1998 | EP0819135A1 Sugar-modified cytostatics |
| 01/21/1998 | EP0819129A1 Pyrazole derivatives and processes for the preparation thereof |
| 01/21/1998 | EP0819128A1 Tricyclic compounds useful in the treatment of cell proliferative disorders |
| 01/21/1998 | EP0819121A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 01/21/1998 | EP0819120A1 Tricyclic compounds useful for inhibition of farnesyl protein transferase |
| 01/21/1998 | EP0819107A1 9-substituted porphycenes |
| 01/21/1998 | EP0660821B1 Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors |
| 01/21/1998 | EP0536208B1 1,2-dihydro-3h-dibenzisoquinoline-1,3-dione anticancer agents |
| 01/21/1998 | CN1171117A Use of MHC-II binding and/or MHC-II minicking molecules for prevention and/or treatment of inflammatory diseases |
| 01/21/1998 | CN1171113A Mutants of Rb and p53 genes and uses thereof |
| 01/21/1998 | CN1171054A Compound |
| 01/20/1998 | US5710294 Treatment of malignant and other diseases characterized by proliferative growth of undifferentiated cells |
| 01/20/1998 | US5710262 Nucleic acid encoding HB15 polypeptides |
| 01/20/1998 | US5710247 Process and intermediates for the synthesis of LHRH antagonists |
| 01/20/1998 | US5710178 Aryl- and aryloxyalkanoic acids |
| 01/20/1998 | US5710171 Anticancer and antitumor agents |
| 01/20/1998 | US5710167 Hydroxamic acid derivatives with tricyclic substitution for treating degenerative joint diseases |
| 01/20/1998 | US5710163 Benzo f!quinolinones |
| 01/20/1998 | US5710162 Antitumor agents |
| 01/20/1998 | US5710158 Inhibitors of protein tyrosine kinase and epidermal growth factor |
| 01/20/1998 | US5710140 Phenyl heterocycles as COX-2 inhibitors |
| 01/20/1998 | US5710137 Nucleic acids and gene expression for cancer cells |
| 01/20/1998 | US5710136 Inhibition of neovascularization using VEGF-specific oligonucleotides |
| 01/20/1998 | US5710135 Anthracycline prodrugs, method for preparation as well as their use in selective chemotherapy |
| 01/20/1998 | US5710134 Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders |
| 01/20/1998 | US5710022 Nuclear mitotic phosphoprotein |
| 01/20/1998 | US5710017 DNA encoding a constitutive activator retinoic acid response (CAR) receptor |
| 01/20/1998 | US5710010 Assays for the presence of a mutant EGF receptor |
| 01/20/1998 | US5709996 Self-assembling recombinant papillomavirus capsid proteins |
| 01/20/1998 | US5709860 Induction of cytotoxic T-lymphocyte responses |
| 01/20/1998 | US5709859 Complexes of fusion proteins; antitumor agent; antiinflammatory agents |
| 01/18/1998 | CA2195606A1 Method of increasing efficacy of cancer drugs |
| 01/15/1998 | WO1998001563A2 Adenovirus e4 proteins for inducing cell death |
| 01/15/1998 | WO1998001554A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001552A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001547A1 INHIBITION OF CHRONIC MYELOGENOUS LEUKEMIC CELL GROWTH BY LIPOSOMAL-ANTISENSE OLIGODEOXY-NUCLEOTIDES TARGETING TO Grb2 OR Crk1 |
| 01/15/1998 | WO1998001467A2 Inhibitors of the interaction between p53 and mdm2 |
| 01/15/1998 | WO1998001460A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/15/1998 | WO1998001445A1 Indole derivatives for the treatment of osteoporosis |
| 01/15/1998 | WO1998001156A2 Method for producing chlorins and bacteriochlorins containing polyether |
| 01/15/1998 | WO1998001143A1 Use of artichoke (cynara) extracts |
| 01/15/1998 | WO1998001132A1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
| 01/15/1998 | WO1998001123A1 Down-regulation of dna repair to enhance sensitivity to p53-mediated suppression |
| 01/15/1998 | WO1997032989A3 Recombinant aav vector-based transduction system and use of same |
| 01/15/1998 | CA2741501A1 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to grb2 or crk1 |
| 01/15/1998 | CA2260295A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259957A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259955A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259154A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/15/1998 | CA2259149A1 Inhibitors of the interaction between p53 and mdm2 |
| 01/15/1998 | CA2207141A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/15/1998 | CA2207083A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/14/1998 | EP0818533A2 Novel isoform gene for focal adhesion protein paxillin |
| 01/14/1998 | EP0818459A2 Carbohydrate derivatives |
| 01/14/1998 | EP0818453A1 Benzothiophene compounds and methods of use |
| 01/14/1998 | EP0818443A2 Mercaptoketones and mercaptoalcohols, a process for their preparation and their use as inhibitors of matrix metalloproteinases |
| 01/14/1998 | EP0818442A2 Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor |
| 01/14/1998 | EP0817860A1 Pseudotyped retroviral particles |
| 01/14/1998 | EP0817859A1 Novel recombinant dna vectors for gene therapy |
| 01/14/1998 | EP0817844A1 T-cell receptors and their use in therapeutic and diagnostic methods |
| 01/14/1998 | EP0817795A1 Novel 4-substituted-3-peptidyl-azetidin-2-one derivatives useful as cysteine proteinase inhibitor |
| 01/14/1998 | EP0817780A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 01/14/1998 | EP0817779A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 01/14/1998 | EP0817775A1 Quinazoline derivatives |
| 01/14/1998 | EP0817769A1 Novel borneol esters, process for their preparation and their pharmaceutical use |
| 01/14/1998 | EP0817632A1 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 01/14/1998 | EP0817630A1 Inhibitors of farnesyl-protein transferase |
| 01/14/1998 | EP0817629A1 Inhibitors of farnesyl-protein transferase |
| 01/14/1998 | EP0817627A1 Protein kinase c inhibitors |
| 01/14/1998 | EP0817623A1 Medicaments for the selective treatment of tumour tissues |
| 01/14/1998 | EP0708648A4 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid |
| 01/14/1998 | EP0662950B1 Benzenealkanoic acids for cardiovascular diseases |
| 01/14/1998 | EP0655060B1 Pharmaceutically active diketopiperazines |
| 01/14/1998 | EP0652890B1 Oligonucleotide alkylphosphonothioates |
| 01/14/1998 | EP0651738B1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 01/14/1998 | EP0437488B1 Animal model for human disease |
| 01/14/1998 | EP0394277B1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
| 01/14/1998 | CN1170412A Suger modified nucleosides and their use for synthesis of oligonucleotides |
| 01/14/1998 | CN1170367A Use of 2'-substituted oligonucleotides to down-regulating gene expression |
| 01/14/1998 | CN1170362A Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours |
| 01/14/1998 | CN1169987A Ortho-substituen benzoyl guanidine, its preparation, use and mecdicines containing it |